Current role
Biotechnology · Healthcare
Board Member
2024-10-30–present
Robert Kadlec
Board Member
MiNK Therapeutics, Inc. (INKT)Equibles does not estimate personal net worth.
Get an email with a short summary when MiNK Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get INKT alertsAbout Robert Kadlec
Robert Kadlec is recorded as Board Member at MiNK Therapeutics, Inc. (INKT) since October 30, 2024. MiNK Therapeutics, Inc. reported in an 8-K filed October 31, 2024 that Robert Kadlec was appointed Class II director, effective October 30, 2024. MiNK Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at MiNK Therapeutics, Inc. includes Melissa Orilall (CFO), Austin Charette (Chief Accounting Officer), Dr. John Holcomb (Board Member) and 4 others.
“On October 30, 2024, the Board of Directors (the "Board") of MiNK Therapeutics Inc., ("MiNK") elected Dr. Robert Kadlec to become a Class II director of MiNK with an initial term that expires at MiNK's annual meeting of stockholders in 2026.”
Affiliation history
-
Current
2024-10-30–present
Company network
Leadership on record at MiNK Therapeutics, Inc.
- Melissa Orilall CFO
- Austin Charette Chief Accounting Officer
- Dr. John Holcomb Board Member
- Jennifer Buell Board Member
- John Holcomb Board Member
- Peter Behner Board Member
- Ulf Wiinberg Board Member